Case Reports

Biomarkers are intended to replace surrogate endpoints in clinical trials process. Surrogate markers are used to conduct clinical trial and gather a number of endpoints which is impractical when the primary end point is undesired or the event number is small. Biomarkers help in the diagnostics and clinical development processes. Biomarkers case study plays an important role in finding new treatments for the patients who need new drugs and to be used widely in various clinical practices.